HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
Strict embargo: 23.30 hrs BST
Wednesday, 15 May, 2024
Peer-reviewed
Observational
People
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK.
Until now, there had been concerns that the HPV vaccine could have an unequal impact across society. After carrying out the longest follow-up on the effectiveness of the HPV vaccine, researchers at Queen Mary University of London concluded the HPV vaccination programme in England is helping to close some inequalities ...








